C. Emmas

First name
C.
Last name
Emmas
Boggon, R. ., van Staa, T. P., Timmis, A. ., Hemingway, H. ., Ray, K. K., Begg, A. ., … Fox, K. A. (2011). Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction\textendasha hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. http://doi.org/10.1093/eurheartj/ehr340
Bakhai, A. ., Rigney, U. ., Hollis, S. ., & Emmas, C. . (2012). Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.2308
Rapsomaniki, E. ., Thuresson, M. ., Yang, E. ., Blin, P. ., Hunt, P. ., Chung, S. C., … Hemingway, H. . (2016). Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes. http://doi.org/10.1093/ehjqcco/qcw004
Wilding, J. ., Bailey, C. ., Rigney, U. ., Blak, B. ., Beekman, W. ., & Emmas, C. . (2016). Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study. Diabetes Ther. http://doi.org/10.1007/s13300-016-0193-8
Wilding, J. ., Bailey, C. ., Rigney, U. ., Blak, B. ., Kok, M. ., & Emmas, C. . (2017). Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. Prim Care Diabetes. http://doi.org/10.1016/j.pcd.2017.04.004